Jerry R Greenfield (J R Greenfield)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 31

Top Topics

Insulin Resistance

Chronic Kidney Disease

Glycemic Control

Top Venues

Internal medicine journal

Diabetic medicine : a journal of the British Diabetic Association

British journal of clinical pharmacology

Acta diabetologica

This page only lists publications with an associated author ORCID identifier.

Publications

Ruth Frampton, Jennifer R Snaith, Samantha L Hocking, Deborah Jane Holmes-Walker, Nicholas Olsen, Jerry R Greenfield
Reducing cardiometabolic risk with semaglutide in type 1 diabetes (RESET1): Study protocol of a phase 2 double-blinded randomised placebo-controlled trial. Diabetic medicine : a journal of the British Diabetic Association (2024)
Annabelle G Hayes, Mark J Penny, Karina Aivazian, Jerry R Greenfield
Acute Interstitial Nephritis and Oxalate Nephropathy After Rapid Pasireotide Response in Treatment-resistant Acromegaly. JCEM case reports 2 (5) (2024)
Tamara Y Milder, Jialing Lin, Sallie-Anne Pearson, Jerry R Greenfield, Richard Osborne Day, Sophie Lena Stocker, Brendon L Neuen, Michael O Falster, Juliana de Oliveira Costa
Use of, time to, and type of first add-on anti-hyperglycaemic therapy to metformin in Australia, 2018-2022. British journal of clinical pharmacology (2024)
Juliana de Oliveira Costa, Jialing Lin, Tamara Y Milder, Jerry R Greenfield, Richard Osborne Day, Sophie Lena Stocker, Brendon L Neuen, Alys Havard, Sallie-Anne Pearson, Michael O Falster
Geographic variation in sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide-1 receptor agonist use in people with type 2 diabetes in New South Wales, Australia. Diabetes, obesity & metabolism (2024)
Juliana de Oliveira Costa, Jialing Lin, Tamara Y Milder, Jerry R Greenfield, Richard Osborne Day, Sophie Lena Stocker, Brendon L Neuen, Alys Havard, Sallie-Anne Pearson, Michael O Falster
Geographic variation in sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide-1 receptor agonist use in people with type 2 diabetes in New South Wales, Australia. Diabetes, obesity & metabolism 26 (7) (2024)
Ivan Shen, Jana Stojanova, Malcolm Yeo, Nick Olsen, Ian Lockart, Max Wang, Jan Roggeveld, Hiddo J L Heerspink, Jerry R Greenfield, Richard Osborne Day, Mark Danta
A potential novel treatment for cirrhosis-related ascites: Empagliflozin is safe and tolerable in advanced chronic liver disease. British journal of clinical pharmacology (2024)
Annabelle G Hayes, Mark J Penny, Karina Aivazian, Jerry R Greenfield
Acute Interstitial Nephritis and Oxalate Nephropathy After Rapid Pasireotide Response in Treatment-resistant Acromegaly. JCEM case reports 2 (5) (2024)
Juliana de Oliveira Costa, Jialing Lin, Tamara Y Milder, Jerry R Greenfield, Richard Osborne Day, Sophie Lena Stocker, Brendon L Neuen, Alys Havard, Sallie-Anne Pearson, Michael O Falster
Geographic variation in sodium-glucose cotransporter 2 inhibitor and glucagon-like peptide-1 receptor agonist use in people with type 2 diabetes in New South Wales, Australia. Diabetes, obesity & metabolism 26 (7) (2024)
G Chowdhury, Jane Ellen Carland, S Kumar, N Olsen, Garry G Graham, G Kumarasinghe, C S Hayward, Jerry R Greenfield, P Macdonald, Richard Osborne Day, Sophie Lena Stocker
The safe use of metformin in heart failure patients both with and without T2DM: a cross-sectional and longitudinal study. British journal of clinical pharmacology (2023)
Tamara Y Milder, Sophie Lena Stocker, Melissa Therese Baysari, Richard Osborne Day, Jerry R Greenfield
'We are somehow fixated on this being a diabetes drug': a qualitative study exploring the views of cardiologists and nephrologists about sodium-glucose cotransporter 2 inhibitor initiation. Internal medicine journal (2023)
Tamara Y Milder, Jerry R Greenfield, D A Milder
Peri-procedural ketoacidosis risk with sodium-glucose cotransporter 2 inhibitor use in people without diabetes. Anaesthesia (2023)
Malgorzata Monika Brzozowska, Michelle Isaacs, Dana Bliuc, Paul A Baldock, John A Eisman, Christopher P White, Jerry R Greenfield, Jacqueline R Center
Effects of bariatric surgery and dietary intervention on insulin resistance and appetite hormones over a 3 year period. Scientific reports 13 (1) (2023)
Mansi Tiwary, Tamara Y Milder, Sophie Lena Stocker, Richard Osborne Day, Jerry R Greenfield
Sodium-glucose co-transporter 2 inhibitor therapy: use in chronic kidney disease and adjunctive sodium restriction. Internal medicine journal 52 (10) (2022)
Lisa Mary Raven, Christopher A Muir, Peter S Macdonald, Christopher Simon Hayward, Andrew Jabbour, Jerry R Greenfield
Diabetes medication following heart transplantation: a focus on novel cardioprotective therapies-a joint review from endocrinologists and cardiologists. Acta diabetologica (2022)
Lisa Mary Raven, Penny Morris, Jerry R Greenfield
Hyperglycaemia induced by gamma-butyrolactone. Diabetic medicine : a journal of the British Diabetic Association 39 (8) (2022)
Lisa Mary Raven, Christopher A Muir, Peter S Macdonald, Christopher Simon Hayward, Andrew Jabbour, Jerry R Greenfield
Diabetes medication following heart transplantation: a focus on novel cardioprotective therapies-a joint review from endocrinologists and cardiologists. Acta diabetologica 60 (4) (2022)
Lisa Mary Raven, Christopher A Muir, Peter S Macdonald, Christopher Simon Hayward, Andrew Jabbour, Jerry R Greenfield
Diabetes medication following heart transplantation: a focus on novel cardioprotective therapies-a joint review from endocrinologists and cardiologists. Acta diabetologica 60 (4) (2022)
Lisa Mary Raven, Jerry R Greenfield, Christopher A Muir
Glucagon-like Peptide-1 Receptor Agonist Treatment With Semaglutide in Type 1 Diabetes. JCEM case reports 1 (1) (2022)
Lisa Mary Raven, Christopher A Muir, Peter S Macdonald, Christopher Simon Hayward, Andrew Jabbour, Jerry R Greenfield
Diabetes medication following heart transplantation: a focus on novel cardioprotective therapies-a joint review from endocrinologists and cardiologists. Acta diabetologica 60 (4) (2022)
Shivani Kamlesh Patel, Spiros Fourlanos, Jerry R Greenfield
Comment on 'impact of routine Clinic Measurement of random Serum c-peptide in people with a Clinician Diagnosis of type 1 diabetes'. Diabetic medicine : a journal of the British Diabetic Association 38 (4) (2021)
Jennifer R Snaith, Dorit Samocha-Bonet, Jennifer Evans, Zhixin Liu, Greg M Kowalski, Clinton R Bruce, Deborah Jane Holmes-Walker, Jerry R Greenfield
Insulin resistance in type 1 diabetes managed with metformin (INTIMET): Study protocol of a double-blind placebo-controlled, randomised trial. Diabetic medicine : a journal of the British Diabetic Association 38 (9) (2021)
Daniel P Heidegger, Kirsten E Neal, Shivani Kamlesh Patel, Jerry R Greenfield, Katherine T Tonks
Effect of fasting ketosis and type 1 diabetes on alcohol breath analysis technology used in Australia. Internal medicine journal 51 (9) (2021)
Tamara Y Milder, Richard Osborne Day, Sophie L Stocker, Jerry R Greenfield
Should the cardio-protective properties of sodium-glucose cotransporter 2 inhibitors dictate therapeutic decision-making in patients with type 2 diabetes. Internal medicine journal 50 (5) (2021)
Tamara Y Milder, Sophie L Stocker, Richard O Day, Jerry R Greenfield
Potential Safety Issues with Use of Sodium-Glucose Cotransporter 2 Inhibitors, Particularly in People with Type 2 Diabetes and Chronic Kidney Disease. Drug safety 43 (12) (2020)
Jennifer R Snaith, Jerry R Greenfield
COVID-19: it's changed us. Internal medicine journal 50 (9) (2020)
Thaw D Htet, Anastasia Godneva, Zhixin Liu, Eliza Chalmers, Dmitry Kolobkov, Jennifer R Snaith, Renee Richens, Krisztina Toth, Mark Danta, Tien-Ming Hng, Eran Elinav, Eran Segal, Jerry R Greenfield, Dorit Samocha-Bonet
Rationale and design of a randomised controlled trial testing the effect of personalised diet in individuals with pre-diabetes or type 2 diabetes mellitus treated with metformin. BMJ open 10 (10) (2020)
Joanne E Taylor, Lesley V Campbell, Jerry R Greenfield
Author reply. Internal medicine journal 49 (4) (2019)
Monika Fazekas-Lavu, Michael Reyes, Monique Malouf, Marshall Plit, Adrian Havryk, Lesley V Campbell, Jacqueline R Center, Allan R Glanville, Jerry R Greenfield
High prevalence of diabetes before and after lung transplantation: target for improving outcome? Internal medicine journal 48 (8) (2019)
Christina Abdel Shaheed, Jane E Carland, Garry G Graham, Sophie L Stocker, Greg Smith, Mark Hicks, Kenneth M Williams, Timothy Furlong, Peter Macdonald, Jerry R Greenfield, Felicity C Smith, Gina Chowdhury, Richard O Day
Is the use of metformin in patients undergoing dialysis hazardous for life? A systematic review of the safety of metformin in patients undergoing dialysis. British journal of clinical pharmacology 85 (12) (2019)
Joanne E Taylor, Lesley V Campbell, Lulu Zhang, Jerry R Greenfield
High diabetes prevalence and insulin medication errors in hospital patients. Internal medicine journal 48 (12) (2019)
Jerry R Greenfield, Ken Ho
Paul Lee, 1977-2017. Internal medicine journal 48 (4) (2018)